Progyny Inc (NAS:PGNY)
$ 26.67 -0.33 (-1.22%) Market Cap: 2.54 Bil Enterprise Value: 2.22 Bil PE Ratio: 43.72 PB Ratio: 4.48 GF Score: 85/100

Progyny Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript

Sep 17, 2020 / 03:45PM GMT
Release Date Price: $27.39 (-5.88%)
Michael Aaron Cherny
BofA Merrill Lynch, Research Division - Director

Good day, everyone, and thank you so much for joining us for this session of the BofA Global Healthcare Conference. It's my absolute pleasure to have with us Progyny, somewhat recently public company. With us is CEO, David Schlanger. David, thanks so much for joining us today. We're going to have a bit of an informal chat. But maybe for people who are new to the Progyny story, can you just give a little sense of what exactly Progyny does within the fertility market and where that value and key value differentiation comes for your business?

David J. Schlanger
Progyny, Inc. - CEO & Director

Well, I'll start with what we do. And we can take it from there. So Progyny is a fertility benefits manager. We provide a fully carved-out fertility benefit solution for large self-insured employers. So what that essentially means is that when one of those employers want to provide fertility coverage to their employees, they do it through us. It's fully carved out from the health plan so that when an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot